DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples

[1]  D. Moher,et al.  Steps toward more complete reporting of systematic reviews of diagnostic test accuracy: Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy (PRISMA-DTA) , 2019, Systematic Reviews.

[2]  N. Pavlidis,et al.  The Developing Story of Predictive Biomarkers in Colorectal Cancer , 2019, Journal of personalized medicine.

[3]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[4]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[5]  S. Bagaria,et al.  Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction , 2018, Front. Oncol..

[6]  M. W. Ørntoft,et al.  Review of Blood‐Based Colorectal Cancer Screening: How Far Are Circulating Cell‐Free DNA Methylation Markers From Clinical Implementation? , 2018, Clinical colorectal cancer.

[7]  David H. Murray,et al.  Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection , 2018, Clinical Epigenetics.

[8]  L. Pan,et al.  Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer , 2018, Disease markers.

[9]  C. Yi,et al.  Liquid biopsies: DNA methylation analyses in circulating cell-free DNA. , 2018, Journal of genetics and genomics = Yi chuan xue bao.

[10]  P. Marcato,et al.  Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum , 2018, Cancers.

[11]  A. El-Shal,et al.  Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients. , 2018, Gene.

[12]  E. Sakhinia,et al.  BMP3 promoter hypermethylation in plasma-derived cell-free DNA in colorectal cancer patients , 2018, Genes & Genomics.

[13]  A. Goel,et al.  Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives , 2017, Seminars in cancer biology.

[14]  A. Kalmár,et al.  Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples , 2017, Epigenetics.

[15]  P. Madsen,et al.  Hypermethylated DNA, a circulating biomarker for colorectal cancer detection , 2017, PloS one.

[16]  Haiping Wu,et al.  Digital quantification of gene methylation in stool DNA by emulsion-PCR coupled with hydrogel immobilized bead-array. , 2017, Biosensors & bioelectronics.

[17]  M. van Engeland,et al.  Details matter: the role of genomic location and assay standardization in DNA methylation analyses. , 2017, Epigenomics.

[18]  E. Jamal,et al.  Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. , 2017, Experimental and molecular pathology.

[19]  M. Houshmand,et al.  Assessment of Bone Morphogenetic Protein 3 Methylation in Iranian Patients with Colorectal Cancer , 2017, Middle East journal of digestive diseases.

[20]  Massoud Saidijam,et al.  Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method. , 2017, Oncology letters.

[21]  J. Ioannidis,et al.  Waste, Leaks, and Failures in the Biomarker Pipeline. , 2017, Clinical chemistry.

[22]  Rui Zhang,et al.  Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer , 2017, Oncotarget.

[23]  M. Agostini,et al.  Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients , 2017, International journal of cancer.

[24]  H. Prenen,et al.  Current and future biomarkers in the treatment of colorectal cancer , 2017, Acta clinica Belgica.

[25]  N. Rosenfeld,et al.  Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.

[26]  Yvette N. Lamb,et al.  Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer , 2017, Molecular Diagnosis & Therapy.

[27]  S. Hines,et al.  The short-term impact of colorectal cancer treatment on physical activity, functional status and quality of life: a systematic review , 2017, JBI database of systematic reviews and implementation reports.

[28]  Lawrence C. LaPointe,et al.  Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer , 2016, Genes.

[29]  P. Mokarram,et al.  Epigenetic biomarkers in colorectal cancer: premises and prospects , 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[30]  P. Madsen,et al.  Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[31]  Y. Jung,et al.  Field Cancerization in Sporadic Colon Cancer , 2016, Gut and liver.

[32]  Ajay Goel,et al.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer. , 2016, Epigenomics.

[33]  J. Ji,et al.  OSMR and SEPT9: promising biomarkers for detection of colorectal cancer based on blood-based tests , 2016 .

[34]  William M. Grady,et al.  Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. , 2015, Gastroenterology.

[35]  G. Lippi,et al.  Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer , 2015, PloS one.

[36]  P. Jin,et al.  Performance of a second‐generation methylated SEPT9 test in detecting colorectal neoplasm , 2015, Journal of gastroenterology and hepatology.

[37]  U. Gottschalk,et al.  Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer , 2015, Journal of Cancer Research and Clinical Oncology.

[38]  Masao Tanaka,et al.  Comparative detection of aberrantly methylated DNA in preoperative and postoperative stool from patients with colorectal cancers , 2015, The International journal of biological markers.

[39]  Weiwei Dong,et al.  Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer , 2014, Oncology letters.

[40]  A. Kalmár,et al.  Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA , 2014, PloS one.

[41]  M. Hernán,et al.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. , 2014, JAMA.

[42]  K. Hibi,et al.  Serum vimentin methylation as a potential marker for colorectal cancer. , 2014, Anticancer research.

[43]  A. Amiot,et al.  The Detection of the Methylated Wif-1 Gene Is More Accurate than a Fecal Occult Blood Test for Colorectal Cancer Screening , 2014, PloS one.

[44]  J. Souverijn,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[45]  Jian Qi,et al.  Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. , 2014, World journal of gastroenterology.

[46]  H. Aburatani,et al.  Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients , 2014, Cancer medicine.

[47]  Bing-sheng Li,et al.  Validation of methylation-sensitive high-resolution melting (MS-HRM) for the detection of stool DNA methylation in colorectal neoplasms. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[48]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[49]  F. Brunetti,et al.  Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer , 2013, BMC Cancer.

[50]  Y. Sato,et al.  UEG Week 2013 Poster Presentations , 2013, United European Gastroenterology Journal.

[51]  A. Papavassiliou,et al.  DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer , 2013, Journal of Molecular Medicine.

[52]  G. Lippi,et al.  Epigenetic alteration: new insights moving from tissue to plasma – the example of PCDH10 promoter methylation in colorectal cancer , 2013, British Journal of Cancer.

[53]  M. Fraga,et al.  DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer , 2013, Cancer Prevention Research.

[54]  D. Ahlquist,et al.  Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.

[55]  Thomas Rösch,et al.  Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer , 2013, Gut.

[56]  H. Zhang,et al.  Detection of Hypermethylated Spastic Paraplegia-20 in Stool Samples of Patients with Colorectal Cancer , 2013, International journal of medical sciences.

[57]  A. Goel,et al.  Epigenetics of colorectal cancer. , 2012, Gastroenterology.

[58]  R. Lamerz,et al.  Prognostic role of methylated free circulating DNA in colorectal cancer , 2012, International journal of cancer.

[59]  A. Kalmár,et al.  Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers , 2012, PloS one.

[60]  S. Thibodeau,et al.  The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  Surbhi Jain,et al.  Detection of hypermethylated vimentin in urine of patients with colorectal cancer. , 2012, The Journal of molecular diagnostics : JMD.

[62]  Yuanyuan Xie,et al.  Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. , 2012, Cancer epidemiology.

[63]  K. Kinzler,et al.  Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. , 2012, Gastroenterology.

[64]  H. Nemoto,et al.  Detection of TFPI2 methylation in the serum of colorectal cancer patients. , 2011, Cancer letters.

[65]  Alexander Crispin,et al.  Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer , 2011, The American Journal of Gastroenterology.

[66]  T. Fujiwara,et al.  Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesis. , 2011, Acta medica Okayama.

[67]  Y. Kodera,et al.  p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer. , 2011, Anticancer research.

[68]  R. Lothe,et al.  SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis , 2011, Oncogene.

[69]  Jun Liu,et al.  Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer. , 2011, Clinical and investigative medicine. Medecine clinique et experimentale.

[70]  R. Ned,et al.  Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test , 2011, PLoS currents.

[71]  S. Brachs,et al.  Fraternal twins: Swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions , 2011, Cell Communication and Signaling.

[72]  Hua-yun Chen,et al.  Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. , 2010, Cancer genetics and cytogenetics.

[73]  M. Esteller,et al.  Novel methylation panel for the early detection of colorectal tumors in stool DNA. , 2010, Clinical colorectal cancer.

[74]  Y. Cho,et al.  Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. , 2010, Hepato-gastroenterology.

[75]  David Sidransky,et al.  DNA methylation markers in colorectal cancer , 2010, Cancer and Metastasis Reviews.

[76]  Joobae Park,et al.  Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer , 2009, Clinical Cancer Research.

[77]  N. Matsubara,et al.  Analysis of fecal DNA methylation to detect gastrointestinal neoplasia. , 2009, Journal of the National Cancer Institute.

[78]  S. Goodman,et al.  Sensitive digital quantification of DNA methylation in clinical samples , 2009, Nature Biotechnology.

[79]  D. Park,et al.  Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean Patients , 2009, Diseases of the colon and rectum.

[80]  M. Washington,et al.  Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. , 2009, Clinical chemistry.

[81]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[82]  J. Herman,et al.  N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. , 2009, Journal of the National Cancer Institute.

[83]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.

[84]  I. Holen,et al.  Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[85]  J. Herman,et al.  GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer , 2009, Clinical Cancer Research.

[86]  J. Herman,et al.  Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. , 2009, Cancer research.

[87]  M. Esteller,et al.  Evaluation of stool melting curve analysis of methylated CpG island promoters as an alternative for early noninvasive diagnosis of colorectal tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  J. Millholland,et al.  A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection , 2008, The American Journal of Gastroenterology.

[89]  B. Leggett,et al.  Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development , 2008, Genes, chromosomes & cancer.

[90]  Ren-Min Zhu,et al.  Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. , 2008, World journal of gastroenterology.

[91]  G. Sozzi,et al.  Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer. , 2008, Cancer letters.

[92]  Dao-rong Wang,et al.  Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. , 2008, World journal of gastroenterology.

[93]  H. Fiegl,et al.  SFRP2 methylation in fecal DNA—a marker for colorectal polyps , 2007, International Journal of Colorectal Disease.

[94]  Zhaohui Huang,et al.  Hypermethylation of SFRP2 as a Potential Marker for Stool-Based Detection of Colorectal Cancer and Precancerous Lesions , 2007, Digestive Diseases and Sciences.

[95]  Fan Yang,et al.  Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. , 2007, World journal of gastroenterology.

[96]  L. Mariani,et al.  Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. , 2005, Journal of the National Cancer Institute.

[97]  L. Myeroff,et al.  Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. , 2005, Journal of the National Cancer Institute.

[98]  George A. Calin,et al.  Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer , 2004, Cancer Research.

[99]  M. Widschwendter,et al.  Methylation changes in faecal DNA: a marker for colorectal cancer screening? , 2004, The Lancet.

[100]  A. Nakao,et al.  Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients , 2003, International journal of cancer.

[101]  H. Kuwano,et al.  High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. , 2003, Cancer letters.

[102]  Hiroshi Nakayama,et al.  Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. , 2002, Cancer letters.

[103]  Dr. med. Hans Leyden Bericht über die am I. September 1902 in Spanien veranstaltete Krebssammelforschung , 1904, Journal of Cancer Research and Clinical Oncology.

[104]  K. El Bairi,et al.  Decoding colorectal cancer epigenomics. , 2018, Cancer genetics.

[105]  M. Tavallaei,et al.  Evaluation of the Epigenetic Biomarker Bone Morphogenic Protein 3 for Colorectal Cancer Diagnosis , 2018 .

[106]  K. Ho,et al.  An inconvenient truth: our routine imaging pathway for loin pain resulted in superfluous radiation exposure , 2014 .

[107]  Abstracts of the 30th German Cancer Congress. February 22-25, 2012. Berlin, Germany. , 2012, Journal of cancer research and clinical oncology.

[108]  Y. Yuasa Epigenetics in molecular epidemiology of cancer a new scope. , 2010, Advances in genetics.

[109]  S. Markowitz,et al.  Improved fecal DNA test for colorectal cancer screening. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[110]  Gerta Rucker,et al.  Bmc Medical Research Methodology Open Access the Relationship between Quality of Research and Citation Frequency , 2006 .

[111]  T. Anthony,et al.  The Effect of Treatment for Colorectal Cancer on Long-Term Health-Related Quality of Life , 2001, Annals of Surgical Oncology.

[112]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.